44 results
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
Adjuvant therapies in critical ... steroids to treat infectious ... respiratory distress syndrome ... #Pharmacology # ... Management #Treatment
Antibiotics for Intraabdominal Infection. 
Use your local antimicrobial susceptibility data for selecting the best empiric treatment!
Intraabdominal Infection ... AAST 2021 global clinical ... intra-abdominal infections ... infectiousdiseases #management ... #pharmacology #
Disseminated Gonococcal Infection - Diagnosis and Management Summary

Bacteremic spread of the Gram-negative diplococci Neisseria gonorrhoeae. History
Diagnosis and Management ... Arthritis-Dermatitis syndrome ... Purulent Arthritis Syndrome ... Distal joints, knees ... gonorrhea #Diagnosis #Management
Common Variable Immunodeficiency (CVID)

What?
CVID: Immunodeficiency disorder with hypogammaglobulinemia -> increased infection risk secondary to impaired B-cell
to 8 years Clinical ... and M panel Management ... : • Nephrotic syndrome ... (Epstein-Barr syndrome ... hematology #diagnosis #management
Campylobacter
Clinical 
 • Fever 
 • Abdominal pain 
 • Diarrhea (bloody stools) 
 • Vomiting
Campylobacter Clinical ... Guillain-Barré syndrome ... Management ... • Supportive (infection ... Campylobacter #Diagnosis #Management
IgA Vasculitis – Henoch Scholein Purpura: Pathogenesis and Clinical Findings

 - Infectious Agents - 50% have
Pathogenesis and Clinical ... Findings - Infectious ... respiratory tract infections ... nephrotic/nephritic syndrome ... arthritis (especially knees
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
Constitutional Syndromes ... Aplastic Anemia Clinical ... Neutropenia - recurrent infections ... Idiopathic • Infections ... hematology #diagnosis #management
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Treatment of COVID-19 Infection ... highlighted circle= clinical ... Treatment #COVID19 #Pharmacology ... #Table #Management
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Cytokine Activation Syndrome ... respiratory tract infection ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Syndrome ... response preceding infection ... meningococcal, H1N1) Clinical ... Guillain-Barre Clinical ... #diagnosis #management